SCHEMBL8407138

SCHEMBL8407138

CCN(C(=O)C(CC#N)CC#N)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
GLA P06280 1/20 0.54
TSHR P16473 1/20 0.54
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
TP53 P04637 2/20 0.44
HTT P42858 1/20 0.41
USP2 O75604 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ATM Q13315 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HPGD P15428 2/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3092712 0.86 ALDH1A1 (0.53) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL8407133 0.85 NPC1 (0.48) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL8407136 0.81 IDE (0.44) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL28389819 0.78 ALDH1A1 (0.63) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL3838077 0.77 ALDH1A1 (0.61) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL18765958 0.76 ALDH1A1 (0.66) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL11647636 0.76 TSHR (0.59) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL11897377 0.75 ALDH1A1 (0.63) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL29216481 0.75 ALDH1A1 (0.69) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL4055696 0.73 ALDH1A1 (0.61) ALDH1A1GLATSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5994362-A ADMINISTERING FINASTERIDE AND CASODEX MERCK & CO., INC. (US) 1999-11-30 US disclosed
EP-0514056-A2 Use of estrogens or antiandrogens for reversal of male sexual phenotype in poultry MERCK & CO. INC. (US) 1992-11-19 EP disclosed
WO-1992016233-A1 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF PROSTATIC CANCER CONTAINING A 5 ALPHA REDUCTASE INHIBITOR AND AN ANTIANDROGEN MERCK & CO., INC. (US) 1992-10-01 WO disclosed
US-4282218-A ANTIANDROGENS IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1981-08-04 US disclosed
US-4239776-A Anti-androgenic amides IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1980-12-16 US disclosed
EP-0002309-A2 Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1979-06-13 EP disclosed